Identification and measurement of genomic biomarkers of nephrotoxicity

Federico M Goodsaid1

  • 1Department of Genetic and Molecular Toxicology, Schering-Plough Research Institute, 144 Route 94, Lafayette, NJ 07871, USA. federico.goodsaid@fluidigm.com

Insights

Genomic biomarkers, like kidney injury molecule transcript levels, can predict drug-induced toxicity. This aids in accelerating drug discovery and development by identifying potential kidney damage early.

Area of Science:

  • Pharmacogenomics
  • Toxicology
  • Biomarker Discovery

Background:

  • Drug discovery necessitates novel toxicity measurements.
  • Genomic biomarkers offer potential for predicting drug toxicity.
  • Early identification of toxicity is crucial for drug development.

Purpose of the Study:

  • To explore the utility of genomic biomarkers in predicting drug-induced toxicity.
  • To evaluate transcript levels of specific genes as indicators of nephrotoxicity.

Main Methods:

  • Analysis of gene transcript levels.
  • Identification and evaluation of potential genomic biomarkers.
  • Focus on genes related to kidney injury.

Main Results:

  • Transcript levels for kidney injury molecule genes were identified.
  • These transcript levels show potential as genomic biomarkers for nephrotoxicity.

Conclusions:

  • Genomic biomarkers, specifically kidney injury molecule transcript levels, can serve as predictors of drug-induced nephrotoxicity.
  • Utilizing such biomarkers can enhance the efficiency of drug discovery and development.

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...